Methylglyoxal bis-guanylhydrazone in advanced bladder cancer.

[1]  W. Jones.  Effective palliation of advanced breast cancer with weekly low dose epirubicin. , 1989, European journal of cancer & clinical oncology.

[2]  L. Pirtoli,et al.  Weekly Epirubicin in Advanced Breast Cancer , 1988, Tumori.

[3]  N. Geller,et al.  M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. , 1988, The Journal of urology.

[4]  A. Yagoda.  Chemotherapy of urothelial tract tumors , 1987, Cancer.

[5]  R. J. Cersosimo,et al.  Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  W. Mattsson,et al.  Phase II study of weekly low-dose 4'-epi-doxorubicin in advanced postmenopausal breast cancer. , 1984, Cancer treatment reports.

[7]  H. Sigurdsson,et al.  Weekly-dose doxorubicin (WDA) in advanced breast cancer. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  T. Landberg,et al.  A weekly schedule of low-dose doxorubicin in treatment of advanced breast cancer. , 1982, Clinical therapeutics.